ScienceDaily (Sep. 3, 2008) — Gynaecological screening tests for
cervical cancer have been available to all women in Sweden for almost four
decades. Despite this, many immigrant women have a higher risk of developing
the disease than Swedish-born women, according to a new study from
Karolinska Institutet.
This is particularly the case for women from other Nordic countries and
Central America, the differences being linked to, amongst other things,
variation in the incidence of the Human Pappiloma Virus (HPV) around the
world. HPV is a significant risk factor for cervical cancer.
"But there are other risk factors too, such as smoking, sexual habits and
not taking screening tests, which make it interesting to compare cervical
cancer rates between different groups of immigrant women in Sweden and
native Swedes," says Professor Pär Sparén, who has led the study at the
Department of Medical epidemiology and Biostatistics.
The study included more than 750,000 resident immigrant women from different
countries, all of whom are registered on Karolinska Institutet’s national
database of women’s health. During the period under study (1968 to 2004)
there were 1,991 cases of cervical cancer in this group. Compared with
Swedish-born women in general, this represents a slightly higher risk of
developing the disease (10 per cent). Also, the incidence proportion of
cervical cancer amongst women who had immigrated to Sweden was lower than
amongst women in their respective countries.
However, the study also shows wide variation between the immigrant groups.
Women from east Africa generally were five times less likely to develop
cervical cancer than Swedish-born women, while women from southern Asia were
half as likely. Conversely, the risk was much higher for women from Norway
and Denmark (70 per cent and 80 per cent, respectively) and Central America
(150 per cent).
Professor Sparén’s team also observed that the risk of cervical cancer
increased with the age of entry into Sweden, but declined during their
period of residency in their new homeland. Professor Sparén believes that
his findings are important for the more effective prevention of cervical
cancer through, for example, targeted screening programmes.
"We need to introduce targeted screening for the prevention of cervical
cancer amongst high-risk groups, particularly women over 50 during their
first ten years in Sweden," he says.
The study, which was funded with a grant from the Swedish Council for
Working Life and Social Research (FAS) and the National Health Care Sciences
Postgraduate School at Karolinska Institutet, was a joint project with
Tehran University of Medical Sciences in Iran and Mälardalen University.
Source : Karolinska Institutet, via AlphaGalileo.